Literature DB >> 16810707

Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy.

Sally-Ann Fancy1, Olaf Beckonert, Gareth Darbon, Warren Yabsley, Rosalind Walley, David Baker, George L Perkins, Frank S Pullen, Klaus Rumpel.   

Abstract

Metabonomics is a relatively new field of research in which the total pool of metabolites in body fluids or tissues from different patient groups is subjected to comparative analysis. Nuclear magnetic resonance (NMR) spectroscopy is the technology that is currently most widely used for the analysis of these highly complex metabolite mixtures, and hundreds of metabolites can be detected without any upfront separation. We have investigated in this study whether gas chromatography (GC) separation in combination with flame ionisation detection (FID) and mass spectrometry (MS) detection can be used for metabolite profiling from urine. We show that although GC sample preparation is much more involved than for NMR, hundreds of metabolites can reproducibly be detected and analysed by GC. We show that the data quality is sufficiently high--particularly if appropriate baseline correction and time-warping methods are applied--to allow for data comparison by chemometrics methods. A sample set of urines from eleven healthy human volunteers was analysed independently by GC and NMR, and subsequent chemometrics analysis of the two datasets showed some similar features. As judged by NIST database searches of the GC/MS data some of the major metabolites that are detected by NMR are also visible by GC/MS. Since in contrast to NMR every peak in GC corresponds to a single metabolite, the electron ionisation spectra can be used to quickly identify metabolites of interest if their reference spectra are present in a searchable database. In summary, we show that GC is a method that can be used as a complementary tool to NMR for metabolite profiling of urine samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16810707     DOI: 10.1002/rcm.2583

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  8 in total

1.  Evaluation of GC-APCI/MS and GC-FID as a complementary platform.

Authors:  Tiziana Pacchiarotta; Ekaterina Nevedomskaya; Alegria Carrasco-Pancorbo; André M Deelder; Oleg A Mayboroda
Journal:  J Biomol Tech       Date:  2010-12

2.  Development of tissue-targeted metabonomics. Part 1. Analytical considerations.

Authors:  Kristin E Price; Craig E Lunte; Cynthia K Larive
Journal:  J Pharm Biomed Anal       Date:  2007-11-29       Impact factor: 3.935

3.  Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry.

Authors:  Oliver Fiehn
Journal:  Trends Analyt Chem       Date:  2008-03       Impact factor: 12.296

4.  Optimization of a direct analysis in real time/time-of-flight mass spectrometry method for rapid serum metabolomic fingerprinting.

Authors:  Manshui Zhou; John F McDonald; Facundo M Fernández
Journal:  J Am Soc Mass Spectrom       Date:  2009-09-17       Impact factor: 3.109

5.  Analytical strategies for studying stem cell metabolism.

Authors:  James M Arnold; William T Choi; Arun Sreekumar; Mirjana Maletić-Savatić
Journal:  Front Biol (Beijing)       Date:  2015-04

6.  Metabolomics-Based Screening of Biofilm-Inhibitory Compounds against Pseudomonas aeruginosa from Burdock Leaf.

Authors:  Zaixiang Lou; Yuxia Tang; Xinyi Song; Hongxin Wang
Journal:  Molecules       Date:  2015-09-08       Impact factor: 4.411

7.  Diversity and sex differences in rectal gland volatiles of Queensland fruit fly, Bactrocera tryoni (Diptera: Tephritidae).

Authors:  Cynthia Castro-Vargas; Gunjan Pandey; Heng Lin Yeap; Michael J Lacey; Siu Fai Lee; Soo J Park; Phillip W Taylor; John G Oakeshott
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

8.  Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach.

Authors:  Xiaojun Gou; Qing Tao; Qin Feng; Jinghua Peng; Yu Zhao; Jianye Dai; Wenyu Wang; Yongyu Zhang; Yiyang Hu; Ping Liu
Journal:  BMC Complement Altern Med       Date:  2013-06-03       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.